Novartis Ag (NVS) Non-cash Items (2009 - 2026)
Novartis Ag's Non-cash Items came in at $3.38 billion for Q2 2026, up 14.3% from $2.95 billion a year earlier and up 35.6% from the prior quarter.
Powered by 
Analysis
Novartis Ag (NVS) Non-cash Items (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Novartis Ag reported Non-cash Items of $11.43 billion, up 3.9% year-over-year; for FY2025, it came in at $11.23 billion, up 9.7% from FY2024.
- Non-cash Items carries a five-year compound annual growth rate of 2.6% (FY2020 to FY2025).
- Going back by year, Non-cash Items was $10.23 billion in FY2024 (-1.3%), $10.37 billion in FY2023 (-2.5%), $10.63 billion in FY2022 and -$6.43 billion in FY2021.
- The Q2 2026 figure represents the highest quarterly Non-cash Items since Q4 2016.
- Year-over-year, Non-cash Items increased in five of the last eight quarters, with growth averaging 9.5%.
- The fastest year-over-year change in Non-cash Items over five years came in Q2 2022 (growth of 61.1%), and the weakest in Q4 2023 (a decline of 35.0%).
- Business Quant data shows NVS's Non-cash Items at $2.49 billion (Q1 2026), $3.3 billion (Q4 2025) and $2.26 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.38 Bn |
| Mar 31, 2026 | 2.49 Bn |
| Dec 31, 2025 | 3.30 Bn |
| Sep 30, 2025 | 2.26 Bn |
| Jun 30, 2025 | 2.95 Bn |
| Mar 31, 2025 | 2.71 Bn |
| Dec 31, 2024 | 2.71 Bn |
| Sep 30, 2024 | 2.63 Bn |
| Jun 30, 2024 | 2.40 Bn |
| Mar 31, 2024 | 2.50 Bn |
| Dec 31, 2023 | 1.79 Bn |
| Sep 30, 2023 | 3.33 Bn |
| Jun 30, 2023 | 2.57 Bn |
| Mar 31, 2023 | 2.68 Bn |
| Dec 31, 2022 | 2.76 Bn |
| Sep 30, 2022 | 2.92 Bn |
| Jun 30, 2022 | 3.06 Bn |
| Mar 31, 2022 | 2.35 Bn |
| Dec 31, 2021 | -11.94 Bn |
| Sep 30, 2021 | 2.38 Bn |
API Access
Novartis Ag Non-cash Items API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-cash-items&ticker=NVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-cash-items", "ticker": "NVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-cash-items&ticker=NVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();